Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Warren Eric, Directeur Commercial. Insider active across 2 companies, notably Esperion Therapeutics, Inc.. Aggregated, 35 disclosures have been recorded. Split: 1 buy · 28 sells. Total volume traded: €406k. History available since 14 March 2022. The latest transaction was disclosed on 21 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Warren Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
526 shares@ US$1.78231.3% of flowCommon StockSEC:0001628280-23-008609:0
25 of 35 declarations
About Warren Eric
Warren Eric is Chief Commercial Officer at Esperion Therapeutics, Inc. (XNAS). The record shows 31 filings in total, and for the recent set tracked from 2022-03-16 to 2025-04-21, the reported aggregated amounts are EUR 7,431 in buys and EUR 58,437 in sells, with a modal transaction nature of sale.